Strickland to hold new professorship; Blind recognized by genetics society
Strickland to hold new professorship
Sidney Strickland, a professor, dean of graduate and postgraduate studies, and vice president for educational affairs at Rockefeller University, will be the first person to hold that university’s new Fisher Center named professorship for neurodegenerative disease research.
Strickland’s lab studies the contribution of vascular dysfunction to the development of Alzheimer’s disease; they found that beta-amyloid protein can promote clotting and inflammation in the brain by interacting with fibrinogen and activating coagulation factor FXII. The work has suggested new molecular mechanisms for the widely studied beta-amyloid protein to contribute to Alzheimer’s pathogenesis and has linked the disease to other common maladies of aging, such as hypertension and cardiovascular disease.
The position, funded by the Fisher Center for Alzheimer’s Research Foundation, will support research into neurodegenerative diseases. It extends the Fisher Center’s partnership with Rockefeller University; the university is also home to the foundation’s flagship lab of 40 scientists focused on Alzheimer’s disease. Strickland has been a member of the Fisher Center’s neuroscience advisory committee since 2019.
Blind recognized by GSA
Raymond D. Blind, an assistant professor at Vanderbilt University, was named in early March a member of the inaugural cohort for the Genetics Society of America’s Presidential Membership Initiative. This competitive program aims to diversify the GSA membership while providing professional-development programming and support for early-career scientists.
Blind’s lab studies how nuclear inositides and inositols regulate chromatin-bound proteins. He recently completed a two-year stint as a junior associate editor for the Journal of Lipid Research, an American Society for Biochemistry and Molecular Biology publication. (Read our short profile.)
Blind will give a talk titled “The acyl chains of phosphoinositides alter the structure and function of nuclear receptor steroidogenic factor-1” at a special session on lipid diversity and disease at the 2021 ASBMB Annual Meeting. The session will be at 2:15 p.m. Eastern on Thursday, April 29.
Enjoy reading ASBMB Today?
Become a member to receive the print edition monthly and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
MOSAIC scholar explores enzymes
Organic chemist Edwin Alfonzo's scientific journey took an unexpected turn when he discovered the world of enzymes.
Honors for Wright, Chiu and Flanegan
Awards, promotions milestones and more. Find out what's going on in the lives of ASBMB members.
In memoriam: Michael Waterfield
He was a British biochemist and a pioneer in the cancer research field who opened a proteomics lab at University College London.
Bakers and mentors help a MOSAIC scholar change her life
Joanna-Lynn Borgogna studies the vaginal microbiome, the metabolome and the development of gynecological disorders in reproductive-aged women.
Swapping stethoscope for pipette to understand diabetic retinopathy
MOSAIC scholar Emma M. Lessieur Contreras is inspired by the work of her ophthalmologist father.
Honors for Lemon, Silva and Brownlee
Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.